Literature DB >> 1105112

Prophylactic use of gentamicin in colonic and rectal surgery.

R C Burton, E S Hughes, A M Cuthbertson.   

Abstract

A double-blind trial was performed to test whether a single intramuscular injection of 80 mg of gentamicin would significantly reduce the incidence of septic complications of elective colonic and rectal surgery. The gentamicin was given at the time of anaesthetic premedication, the operations were performed by either of two surgeons, and the patients were followed up by an independent investigator. Eighty patients satisfactorily completed the trial. There was no significant difference in the incidence of postoperative wound infection, intraperitoneal abscess formation and faecal fistula between the 41 patients who received the gentamicin and the 39 who received the placebo. However, the mortality was significantly lower in the gentamicin group, in which there was only one death.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105112     DOI: 10.5694/j.1326-5377.1975.tb106377.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Sepsis and asepsis in large bowel cancer surgery.

Authors:  E S Hughes; F T McDermott; A L Polglase; W R Johnson; E A Pihl
Journal:  World J Surg       Date:  1982-03       Impact factor: 3.352

2.  Intraperitoneally applied gentamicin increases collagen content and mechanical stability of colon anastomosis in rats.

Authors:  Marcel Binnebösel; Karsten Junge; Daniel A Kaemmer; Carsten J Krones; Svetlana Titkova; Michael Anurov; Volker Schumpelick; Uwe Klinge
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

3.  Influence of gentamicin-coded PVDF suture material on the healing of intestinal anastomosis in a rat model.

Authors:  Dominik S Schoeb; Christian D Klink; Andreas Lambertz; Roman Eickhoff; Daniel Busch; Tom F Ulmer; Ulf P Neumann; Marcel Binnebösel
Journal:  Int J Colorectal Dis       Date:  2015-08-12       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.